Matossian, M. D., Burks, H. E., Elliott, S., Hoang, V. T., Bowles, A. C., Sabol, R. A., . . . Collins-Burow, B. M. (2018). Panobinostat suppresses the mesenchymal phenotype in a novel claudin-low triple negative patient-derived breast cancer model. Oncoscience.
Chicago-стиль цитированияMatossian, Margarite D., et al. "Panobinostat Suppresses the Mesenchymal Phenotype in a Novel Claudin-low Triple Negative Patient-derived Breast Cancer Model." Oncoscience 2018.
MLA-цитированиеMatossian, Margarite D., et al. "Panobinostat Suppresses the Mesenchymal Phenotype in a Novel Claudin-low Triple Negative Patient-derived Breast Cancer Model." Oncoscience 2018.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.